Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in Active Rheumatoid Arthritis
NCT00831922Phase 2Completed
- Sponsor
- AB Science
- Start
- Sep 2004
- Primary completion
- Oct 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of masitinib in rheumatoid arthritis (RA), sponsored by AB Science. Started Sep 2004; status: completed.
02
Drugs
masitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00831922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831922.